Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism—a Review
- 3 September 2019
- journal article
- review article
- Published by Springer Nature in Current Hypertension Reports
- Vol. 21 (10) , 77
- https://doi.org/10.1007/s11906-019-0985-0
Abstract
Steroid profiling and immunohistochemistry are both promising new tools used to improve diagnostic accuracy in the work-up of primary aldosteronism (PA) and to predict treatment outcomes. Herein, we review the recent literature and present an outlook to the future of diagnostics and therapeutic decision-making in patients with PA.Keywords
This publication has 78 references indexed in Scilit:
- Outcomes of Adrenalectomy in Patients with Unilateral Primary Aldosteronism: A ReviewHormone and Metabolic Research, 2012
- Primary Aldosteronism: Results of Adrenalectomy for Nonsingle AdenomaJournal of the American College of Surgeons, 2011
- Adrenal Venous SamplingHypertension, 2011
- Clinical steroid mass spectrometry: A 45-year history culminating in HPLC–MS/MS becoming an essential tool for patient diagnosisThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- A Novel Form of Human Mendelian Hypertension Featuring Nonglucocorticoid-Remediable AldosteronismJournal of Clinical Endocrinology & Metabolism, 2008
- The Aldosteronoma Resolution ScoreAnnals of Surgery, 2008
- A Prospective Study of the Prevalence of Primary Aldosteronism in 1,125 Hypertensive PatientsPublished by Elsevier ,2006
- Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolitesActa Endocrinologica, 2006
- PRODUCTION OF 18‐OXO‐CORTISOL IN SUBTYPES OF PRIMARY ALDOSTERONISMClinical and Experimental Pharmacology and Physiology, 1996
- Role of 18-hydroxylated cortisols in hypertensionJournal of Steroid Biochemistry, 1987